Health Technologies for Women and Children

Advancing innovative health solutions for women and children

Millions of mothers, newborns, and children die unnecessarily—the vast majority of these preventable deaths occur in developing countries. Each year, nearly 300,000 women die  from causes related to pregnancy and childbirth, and more than three million babies die within four weeks of birth. Major causes of maternal deaths include severe bleeding/hemorrhage, infections, eclampsia, and obstructed labor. Major causes of newborn deaths include preterm birth complications, infections, as well as intrapartum-related complications—such as birth asphyxia.

Badge Technology Solutions Global Program

To address the leading causes of maternal and infant death, PATH assesses, develops, adapts, and advances innovative health technologies. The Health Technologies for Women and Children group within the Technology Solutions Global Program collaborates with numerous nongovernmental organizations and public- and private-sector partners, and is involved in task forces, international forums, and committees dedicated to improving health outcomes for women and children.

Mother holds 18 day old infant in India.

Photo: PATH/Mutsumi Metzler.

Our multidisciplinary teams consider potential health impact and feasibility and focus on solutions that are affordable, accessible, acceptable, and sustainable in low-resource settings. We have more than 30 years of experience advancing lower-cost technologies and novel interventions for families around the world.

Currently, our teams are advancing many maternal health technologies such as oxytocin in the Uniject™* device, the nonpneumatic antishock garment, and the uterine balloon tamponade for postpartum hemorrhage; noninvasive methods for anemia detection; blood pressure measurement; and alternative delivery routes of magnesium sulfate for the prevention and treatment of preeclampsia/eclampsia. To address the needs of infants, we are focusing on manual neonatal resuscitators, suction bulbs, oxygen blending, and continuous positive airway pressure for infant respiratory care; chlorhexidine umbilical cord cleansing and gentamicin in the Uniject™ injections system for newborn infection; and human milk banking monitoring and the NIFTY™ cup for safe and effective infant feeding.

To find more in-depth information about our project work go to:

*Uniject is a trademark of BD.
Banner photo: PATH/Jillian Zemanek.

Comments are closed.